Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight Report 2018-2024 - ResearchAndMarkets.com

Research and Markets
Posted on: 15 Feb 18

The "Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024" clinical trials has been added to ResearchAndMarkets.com's offering.

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 report gives comprehensive insight on the clinical and non-clinical parameters related to the emergence and development of role of tubulin inhibitors in the cancer therapy. Report highlights the clinical development of more than 70 cancer tubulin inhibitors in pipeline and shares in-depth dosage/price analysis of 10 cancer tubulin inhibitors commercially available in the market.

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 Report highlights:

  • Clinical Insight on 70 Tubulin Inhibitors in pipeline
  • Dosage & Price Analysis of 10 Commercialized Drugs
  • Patent Approval, Expiry Year & Market Sales Indicators
  • Patent Analysis of Key Drugs
  • Global Cancer Tubulin Inhibitors Clinical Pipeline by Company & Phase
  • Future Perspective of Cancer Tubulin Inhibitors

Key Topics Covered:

1. Microtubules - Moving Target in Cancer Therapy

2. Mechanism of Action & Mechanism of Resistance of Tubulin Inhibitors

3. Microtubules & Their Role in Cellular Stress in Cancer

4. Prognostic Role of Tubulin for Prediction of Cancer Aggressiveness

5. Price & Dosage Analysis of Tubulin Inhibitor Drugs

6. Market Analysis of Tubulin Inhibitors

7. Global Cancer Tubulin Inhibitors Clinical Pipeline Overview

8. Global Cancer Tubulin Inhibitors Clinical Pipeline by Company & Phase

9. Marketed Cancer Tubulin Inhibitors Clinical Insight

10. Global Cancer Tubulin Inhibitors Market Dynamics

11. Future Perspective of Cancer Tubulin Inhibitors

12. Competitive Landscape

  • Abraxis Biosciences
  • Agensys
  • Amgen
  • Celgene
  • Eagle Pharmaceuticals
  • Endocyte
  • Genentech
  • Immunogen
  • Modra Pharmaceuticals
  • Pierre Fabre
  • Roche
  • Sanofi-Aventis
  • Seattle Genetics
  • Tocris Bioscience

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/hr774n/global_cancer?w=4.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180215005757/en/

Business Wire
www.businesswire.com

Last updated on: 15/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.